Your browser doesn't support javascript.
loading
Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA).
Verbus, Emily A; Rossi, Alexander J; Luna, Allen J; Iqbal, Atif; Morris, Van K; Hernandez, Jonathan M.
Affiliation
  • Verbus EA; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, Building 10, Room 4-3740, Bethesda, MD, 20892, USA.
  • Rossi AJ; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, Building 10, Room 4-3740, Bethesda, MD, 20892, USA.
  • Luna AJ; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, Building 10, Room 4-3740, Bethesda, MD, 20892, USA.
  • Iqbal A; Section of Colorectal Surgery, Division of Surgery, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. vankmorris@mdanderson.org.
  • Hernandez JM; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, Building 10, Room 4-3740, Bethesda, MD, 20892, USA. jonathan.hernandez@nih.gov.
Ann Surg Oncol ; 28(8): 4095-4097, 2021 Aug.
Article in En | MEDLINE | ID: mdl-33999346
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Colonic Neoplasms / Circulating Tumor DNA Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Colonic Neoplasms / Circulating Tumor DNA Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: United States